Anti-Inhibitor Coagulant Complex (Aicc) Lyophilized Powder Suppliers & Bulk Manufacturers
Available Forms: Lyophilized Powder (Reconstituted for IV infusion)
Available Strengths: 500 units, 1000 units, and 2500 units
Reference Brands: FEIBA(US)
Category: Blood Disorder
Anti-inhibitor coagulant complex (activated prothrombin complex concentrate) is a plasma-derived bypassing agent that controls and prevents bleeding in people with haemophilia A or B who have developed inhibitors to factor VIII or IX. It comes as lyophilised powder from 500 to 2,500 units. The reference product is FEIBA. Ask PharmaTradz for a quote; we confirm the manufacturer, registration documents and lead time for your country.
Manufacture or export Anti-Inhibitor Coagulant Complex (Aicc) Lyophilized Powder? List it or send an offer →
Product Description: Anti-Inhibitor Coagulant Complex (AICC), such as FEIBA, is approved in the US by the FDA and in the EU via EMA for managing bleeding in hemophilia patients with inhibitors. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews comprehensive clinical and manufacturing information, while the EMA ensures compliance with regional safety and quality requirements. For guidance on dossier preparation, regulatory strategies, and market access, visit PharmaTradz. Ensuring regional compliance is essential for the safe, effective, and timely approval of AICC products worldwide, supporting optimal hemophilia patient care.
Anti-Inhibitor Coagulant Complex (Aicc) Lyophilized Powder — third party manufacturing & bulk supply
Anti-Inhibitor Coagulant Complex (Aicc) Lyophilized Powder is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Anti-Inhibitor Coagulant Complex (Aicc) Lyophilized Powder is supplied as Lyophilized Powder (Reconstituted for IV infusion) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Anti-Inhibitor Coagulant Complex (Aicc) Lyophilized Powder listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Anti-Inhibitor Coagulant Complex (Aicc)... →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Usually 50–100 units/kg, with a maximum of 200 units/kg a day, to treat or prevent bleeds in haemophilia patients with inhibitors.
Thrombotic events, especially at high doses or when combined with emicizumab, which requires dose limits.
At 2–25 °C as lyophilised powder with diluent and transfer devices. Each batch has an official release certificate.
Related Products
Prothrombin Complex Concentrate (Pcc) Injection
Strength:
500 IU and 1,000 IU vials
Form: Injection
Reference Brands: Kcentra (4-factor PCC), Bebulin VH (3-factor PCC)(US)
View DetailsLeucovorin Tablets/Capsule
Strength:
5 mg, 10 mg, 15 mg, 25 mg
Form: Tablets
Reference Brands: Generic leucovorin calcium (originator brand Wellcovorin)
View DetailsPegfilgrastim Injection
Strength:
6 mg per single-use syringe
Form: Injection
Reference Brands: Neulasta, Pelgraz(US), Pegex (Inida)
View DetailsTicagrelor Tablet
Strength:
90 mg, 60 mg
Form: Tablet
Reference Brands: Brilinta(US & EU)
View DetailsHydroxyurea Capsule
Strength:
500 mg, 1000 mg
Form: Capsules
Reference Brands: Droxia(US); Hydrea(US & EU)
View DetailsCrizanlizumab Infusion
Strength:
10 mg/mL
Form: Infusion Solution
Reference Brands: Adakveo(US)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit